These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 23814464)

  • 21. Postherpetic neuralgia: New hopes in prevention with adult vaccination and in treatment with a concentrated capsaicin patch.
    Gawecka E; Viken O
    Scand J Pain; 2012 Oct; 3(4):220-228. PubMed ID: 29913873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 5% lidocaine medicated plaster in elderly patients with postherpetic neuralgia: results of a compassionate use programme in France.
    Clère F; Delorme-Morin C; George B; Navez M; Rioult B; Tiberghien-Chatelain F; Ganry H
    Drugs Aging; 2011 Sep; 28(9):693-702. PubMed ID: 21913735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Treatment of Topical Drugs for Postherpetic Neuralgia: A Network Meta-Analysis.
    Liu X; Wei L; Zeng Q; Lin K; Zhang J
    Pain Physician; 2020 Nov; 23(6):541-551. PubMed ID: 33185370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lidocaine plasters for postherpetic neuralgia?
    BMJ Group
    Drug Ther Bull; 2008 Feb; 46(2):14-6. PubMed ID: 18256177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tolerability of treatments for postherpetic neuralgia.
    Douglas MW; Johnson RW; Cunningham AL
    Drug Saf; 2004; 27(15):1217-33. PubMed ID: 15588117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of post-herpes zoster pain with tramadol. Results of an open pilot study versus clomipramine with or without levomepromazine].
    Göbel H; Stadler T
    Drugs; 1997; 53 Suppl 2():34-9. PubMed ID: 9190323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The safety and efficacy of KAI-1678- an inhibitor of epsilon protein kinase C (εPKC)-versus lidocaine and placebo for the treatment of postherpetic neuralgia: a crossover study design.
    Cousins MJ; Pickthorn K; Huang S; Critchley L; Bell G
    Pain Med; 2013 Apr; 14(4):533-40. PubMed ID: 23438341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intrathecal methylprednisolone for intractable postherpetic neuralgia.
    Kotani N; Kushikata T; Hashimoto H; Kimura F; Muraoka M; Yodono M; Asai M; Matsuki A
    N Engl J Med; 2000 Nov; 343(21):1514-9. PubMed ID: 11087880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topical pain management with the 5% lidocaine medicated plaster--a review.
    Mick G; Correa-Illanes G
    Curr Med Res Opin; 2012 Jun; 28(6):937-51. PubMed ID: 22551228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Postherpetic neuralgia of the left trigeminus nerve V1 : Successful therapy with capsaicin 8% patch].
    Kern KU; Schwickert-Nieswandt M
    Schmerz; 2018 Dec; 32(6):464-467. PubMed ID: 30306307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Review of current guidelines on the care of postherpetic neuralgia.
    Argoff CE
    Postgrad Med; 2011 Sep; 123(5):134-42. PubMed ID: 21904096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tolerability of NGX-4010, a capsaicin 8% dermal patch, following pretreatment with lidocaine 2.5%/prilocaine 2.5% cream in patients with post-herpetic neuralgia.
    Webster LR; Nunez M; Tark MD; Dunteman ED; Lu B; Tobias JK; Vanhove GF
    BMC Anesthesiol; 2011 Dec; 11():25. PubMed ID: 22182397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of the capsaicin 8% patch in the management of peripheral neuropathic pain in European clinical practice: the ASCEND study.
    Mankowski C; Poole CD; Ernault E; Thomas R; Berni E; Currie CJ; Treadwell C; Calvo JI; Plastira C; Zafeiropoulou E; Odeyemi I
    BMC Neurol; 2017 Apr; 17(1):80. PubMed ID: 28431564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of herpes zoster and postherpetic neuralgia.
    Tyring SK
    J Am Acad Dermatol; 2007 Dec; 57(6 Suppl):S136-42. PubMed ID: 18021865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Profile of the capsaicin 8% patch for the management of neuropathic pain associated with postherpetic neuralgia: safety, efficacy, and patient acceptability.
    Laklouk M; Baranidharan G
    Patient Prefer Adherence; 2016; 10():1913-1918. PubMed ID: 27703336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term treatment of neuropathic pain with a 5% lidocaine medicated plaster.
    Wilhelm IR; Tzabazis A; Likar R; Sittl R; Griessinger N
    Eur J Anaesthesiol; 2010 Feb; 27(2):169-73. PubMed ID: 20010108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Efficacy of intracutaneous methylene blue injection for moderate to severe acute thoracic herpes zoster pain and prevention of postherpetic neuralgia in elderly patients].
    Cui JZ; Zhang JW; Zhang Y; Ma ZL
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Oct; 36(10):1377-1381. PubMed ID: 27777201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lidocaine 5% medicated plaster: a review of its use in postherpetic neuralgia.
    Garnock-Jones KP; Keating GM
    Drugs; 2009 Oct; 69(15):2149-65. PubMed ID: 19791831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of topical 5% lidocaine-medicated plasters on sleep and quality of life in patients with postherpetic neuralgia.
    Binder A; Rogers P; Hans G; Baron R
    Pain Manag; 2016; 6(3):229-39. PubMed ID: 26821240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topical lidocaine patch relieves a variety of neuropathic pain conditions: an open-label study.
    Devers A; Galer BS
    Clin J Pain; 2000 Sep; 16(3):205-8. PubMed ID: 11014393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.